Previous Article | Next Article ![]()
Infection and Immunity, February 2002, p. 981-984, Vol. 70, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.70.2.981-984.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Assan Jaye,1 Pauline T. Lukey,3 and Keith P. W. J. McAdam1
TB Research Programme, MRC Laboratories, Fajara, The Gambia,1 Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London,2 Respiratory Systems, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, Hertfordshire United Kingdom3
Received 14 May 2001/ Returned for modification 10 July 2001/ Accepted 22 October 2001
Few human CD8+ T-cell epitopes in mycobacterial antigens have been described to date. Here we have identified a novel HLA-B*35-restricted CD8+ T-cell epitope in Mycobacterium tuberculosis Rv2903c based on a reverse immunogenetics approach. Peptide-specific CD8 T cells were able to kill M. tuberculosis-infected macrophages and produce gamma interferon and tumor necrosis factor alpha.
Present address: Department of Pathology and Microbiology, University of Bristol, Bristol, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»